SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-040115
Filing Date
2023-06-28
Accepted
2023-06-28 21:03:55
Documents
2
Period of Report
2023-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4019
2 EX-24 DOCUMENT attachment1.htm EX-24 4125
  Complete submission text file 0001209191-23-040115.txt   9632
Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Issuer) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARS PHARMACEUTICALS, INC. 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address
Dadoo Rajeev (Reporting) CIK: 0001951685 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39756 | Film No.: 231053991